Header cover image

French (CAC) Life Sciences Industry Analysis

UpdatedJul 27, 2026
DataAggregated Company Financials
Companies3
  • 7D-8.1%
  • 3M6.0%
  • 1Y-4.0%
  • YTD-10.4%

Over the last 7 days, the Life Sciences industry has dropped 8.1%, driven by pullbacks from every company within the industry. However, the industry is down 4.0% over the past year. Looking forward, earnings are forecast to grow by 20% annually.

Industry Valuation and Performance

Has the French Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 27 Jul 2026€27.9b€10.4b€767.3m24.5x36.3x2.7x
Wed, 24 Jun 2026€27.4b€10.3b€689.0m27.4x39.7x2.7x
Fri, 22 May 2026€27.7b€10.3b€690.4m26.5x40.1x2.7x
Sun, 19 Apr 2026€30.7b€10.3b€687.9m29.5x44.7x3x
Tue, 17 Mar 2026€26.5b€10.3b€687.9m26x38.6x2.6x
Thu, 12 Feb 2026€28.4b€10.3b€686.1m27.5x41.4x2.8x
Sat, 10 Jan 2026€33.2b€10.1b€651.0m32.1x51x3.3x
Mon, 08 Dec 2025€31.3b€10.1b€651.0m27.4x48x3.1x
Wed, 05 Nov 2025€30.2b€10.1b€651.0m27.9x46.4x3x
Fri, 03 Oct 2025€29.7b€10.1b€613.3m29.3x48.5x3x
Sun, 31 Aug 2025€28.6b€10.1b€613.3m30.2x46.7x2.8x
Tue, 29 Jul 2025€28.8b€10.1b€613.3m30.5x47x2.9x
Thu, 26 Jun 2025€30.2b€9.8b€567.8m30.3x53.2x3.1x
Sat, 24 May 2025€28.9b€9.8b€567.8m28.7x50.9x2.9x
Mon, 21 Apr 2025€27.3b€9.9b€567.9m25.3x48.2x2.8x
Wed, 19 Mar 2025€29.0b€9.8b€539.0m26.2x53.9x3x
Fri, 14 Feb 2025€30.4b€9.7b€524.2m26.7x58x3.1x
Sun, 12 Jan 2025€28.8b€9.5b€494.1m28.3x58.4x3x
Tue, 10 Dec 2024€27.1b€9.5b€494.1m27.8x54.8x2.9x
Thu, 07 Nov 2024€26.4b€9.5b€494.1m26.3x53.4x2.8x
Sat, 05 Oct 2024€28.3b€9.5b€503.0m32.1x56.2x3x
Mon, 02 Sep 2024€27.9b€9.5b€503.0m30.3x55.5x2.9x
Wed, 31 Jul 2024€27.9b€9.5b€503.0m31.8x55.5x2.9x
Fri, 28 Jun 2024€24.2b€9.3b€518.8m35.3x46.6x2.6x
Sun, 26 May 2024€29.8b€9.3b€522.7m42.8x57.1x3.2x
Tue, 23 Apr 2024€31.1b€9.3b€522.7m44.6x59.4x3.3x
Thu, 21 Mar 2024€37.1b€9.3b€577.7m41.9x64.2x4x
Sat, 17 Feb 2024€34.6b€9.5b€885.8m26.9x39.1x3.6x
Mon, 15 Jan 2024€32.7b€9.5b€885.8m26.7x36.9x3.4x
Wed, 13 Dec 2023€29.9b€9.5b€885.8m25.4x33.7x3.1x
Fri, 10 Nov 2023€27.6b€9.5b€885.8m23.9x31.1x2.9x
Sun, 08 Oct 2023€31.4b€9.7b€1.1b24.7x29.6x3.2x
Tue, 05 Sep 2023€35.3b€9.7b€1.1b26.5x33.3x3.6x
Thu, 03 Aug 2023€36.3b€9.7b€1.1b27.7x34.2x3.7x
Price to Earnings Ratio

34.2x


Total Market Cap: €36.3bTotal Earnings: €1.1bTotal Revenue: €9.7bTotal Market Cap vs Earnings and Revenue0%0%0%
French Life Sciences Industry Price to Earnings3Y Average 47.4x202420252026
Current Industry PE
    There are only 3 companies in the French Life Sciences industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have declined 10% per year over the last three years.
  • Meanwhile revenues for these companies have grown 2.4% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the French Healthcare industry?

FR Market-0.24%
Healthcare-2.75%
Life Sciences-8.12%
Clinical Research and Equipment-8.12%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News